On April 3, 2023 Ashvattha Therapeutics ("Ashvattha"), a clinical-stage company developing a new class of nanomedicines, reported that the company will present preclinical data at the upcoming American Association for Cancer Research (AACR) (Free AACR Whitepaper) and the Association for Research in Vision and Ophthalmology (ARVO) 2023 annual meetings (Press release, Ashvattha Therapeutics, APR 3, 2023, View Source [SID1234629734]). The presentations will showcase the potential of Ashvattha’s pipeline of nanomedicines to transverse tissue barriers to selectively target activated cells in regions of inflammation. The poster presented at AACR (Free AACR Whitepaper) will be published in an online-only Proceedings supplement to the AACR (Free AACR Whitepaper) journal Cancer Research on Friday, April 14.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Details for the presentations are as follows:
AACR Annual Meeting 2023
April 14 – 19, 2023
Orange County Convention Center, Orlando, Florida
Poster Title: A potent macrophage switching drug D-4559 reduces tumor growth in a hepatocellular carcinoma mouse model
Session Title: Late-Breaking Research: Immunology 2
Abstract Presentation Number: LB208
Presenter: Naze Avci, Ph.D., Ashvattha Therapeutics
Date/Time: Tuesday, April 18, 2023, 9:00 a.m. – 12:30 p.m. ET
Location: Poster Section 36
ARVO 2023 Annual Meeting
April 23 – 27, 2023
The New Orleans Ernest N. Morial Convention Center, New Orleans, Louisiana
Title: Oral Formulation Development of the Anti-Angiogenesis Drug D-4517.2 to Treat Age-related Macular Degeneration (wet-AMD) and Diabetic Macular Edema (DME)
Session Title: AMD: New drugs, delivery systems and mechanisms of action 2
Presenter: Natacha Le Moan, Ph.D., Ashvattha Therapeutics
Session Number: 204
Date/Time: Monday, April 24, 2023, 12:45 p.m. – 1:00 p.m. CT
Location: Room R01
Title: Suppression of subretinal neovascularization in Vldlr knockout mice by systemic administration of a targeted VEGF-receptor inhibitor
Session Title: Cellular pathways underlying retinal degeneration
Presenter: Elia Duh, M.D., Johns Hopkins University School of Medicine
Session Number: 415
Poster Presentation Number: 3900-B0180
Date/Time: Wednesday, April 26, 2023, 10:30 a.m. – 12:30 p.m. CT
Location: Exhibit Hall – B